With a random-effect model, shorter OS was observed in non-female cancer patients with high H19 expression than those with low H19 expression (Figure 4; pooling HR = 1.31, 95 % CI = 1.09 - 1.59, p = 0.004). This evidence concerns the gene H19 and cancer.